| 2023/03/31 14:07:27 | |
|---|---|
| Price | |
| 36.50 EUR | |
| Difference | -0.82% (-0.30) |
General attributes
| ISIN | ATMARINOMED6 |
| Symbol | MARI |
| Exchange | Vienna Stock Exchange |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 55 EUR |
| Benchmark | ATX AUSTRIAN TRADED INDEX |
Market data
| Bid (Bid size) | 36.50 EUR (98) |
| Ask (Ask size) | 36.70 EUR (95) |
| Open | 36.50 EUR |
| High | 36.50 EUR |
| Low | 36.50 EUR |
| Close (prev. day) | 36.80 EUR |
| VWAP | 36.50 EUR |
| Volume (pcs) | 38 |
| Trading volume | 1,387.00 |
| Number of trades | 2 |
| Last size | 10 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: MARINOMED BIOTECH AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/03/28 |
|
Global Equity Ratings |
|
| 2023/03/16 |
|
Global Equity Ratings |
|
| 2023/03/10 |
|
Global Equity Ratings |
|
| 2023/02/27 |
|
Global Equity Ratings |
|
| 2023/02/07 |
|
Global Equity Ratings |
|
| 2023/03/31 14:07:27 | |
|---|---|
| Price | |
| 36.50 EUR | |
| Difference | -0.82% (-0.30) |
General attributes
| ISIN | ATMARINOMED6 |
| Symbol | MARI |
| Exchange | Vienna Stock Exchange |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 55 EUR |
| Benchmark | ATX AUSTRIAN TRADED INDEX |
Market data
| Bid (Bid size) | 36.50 EUR (98) |
| Ask (Ask size) | 36.70 EUR (95) |
| Open | 36.50 EUR |
| High | 36.50 EUR |
| Low | 36.50 EUR |
| Close (prev. day) | 36.80 EUR |
| VWAP | 36.50 EUR |
| Volume (pcs) | 38 |
| Trading volume | 1,387.00 |
| Number of trades | 2 |
| Last size | 10 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -38.10% | -54.27% | - |
| Perf (abs.) | -22.40 | -43.20 | - |
| Beta | 0.30 | 0.27 | 0.22 |
| Volatility | 40.27 | 40.84 | 36.45 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 36.66 EUR (234) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 41.14 EUR (1,439) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 52.25 EUR (1,485) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 60.31 EUR (933) |
| YTD High | date | 59.40 EUR (2023/01/03) |
| YTD Low | date | 35.00 EUR (2023/03/13) |
| 52 Weeks High | date | 83.00 EUR (2022/04/04) |
| 52 Weeks Low | date | 35.00 EUR (2023/03/13) |
All listings for MARINOMED BIOTECH AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Vienna Stock Exchange | 2023/03/31 | 14:07 | 36.50 EUR | 0.00 | 2 |
| Tradegate | 2023/03/31 | 22:02 | 36.70 EUR | 0.00 | 1 |
| Stuttgart | 2023/03/31 | 15:59 | 36.10 EUR | 0.00 | 7 |
| Munich | 2023/03/31 | 08:06 | 37.00 EUR | 0.00 | 1 |
| Frankfurt | 2023/03/31 | 08:01 | 35.70 EUR | 0.00 | 1 |
| Duesseldorf | 2023/03/31 | 08:10 | 34.50 EUR | 0.00 | 1 |
| Berlin | 2023/03/31 | 20:54 | 36.60 EUR | 0.00 | 15 |
Company Logo
Contact Details
| MARINOMED BIOTECH AG |
| - - |
| Hovengasse 25 - 2100 Korneuburg |
| Telefon: +43-1-2262-90300 |
| Fax: +43-1-25077-4493 |
| E-mail: office@marinomed.com |
PDF Downloads
| Company report: MARINOMED BIOTECH AG | |
Company Profile
Marinomed Biotech AG is a biopharmaceutical company, which engages in the development of therapies based on patent protected technology platforms. It operates through the Carragelose and Marinosolv segments. The Carragelose segment contains products with anti-viral properties target viral infections of the respiratory tract of different virus strains. The Marinosolv segment refers to the technology platform that increases the bioavailability of hardly soluble compounds for the treatment of sensitive tissues such as nose and eyes. The company was founded by Andreas Grassauer and Eva Prieschl-Grassauer in 2006 and is headquartered in Korneuburg, Austria. |
Members of Management Board
| Andreas Grassauer | Chairman of Managing Board |
| Cornelia Kutzer | Member of Executive Committee |
| Eva Prieschl-Grassauer | Member of Executive Committee |
| Pascal Schmidt | Member of Executive Committee |
Board of directors
| Simon Jules Nebel | Chairman of Supervisory Board |
| Elisabeth Lackner | Member of Supervisory Board |
| Gernot Hofer | Member of Supervisory Board |
| Brigitte Ederer | Member of Supervisory Board |
| Ulrich Kinzel | Member of Supervisory Board |
| Ute Lassnig | Member of Supervisory Board |